We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
61 hedge funds and large institutions have $114M invested in Larimar Therapeutics in 2018 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
85% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 13
81% more capital invested
Capital invested by funds: $62.9M → $114M (+$51.1M)
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
57% more call options, than puts
Call options by funds: $297K | Put options by funds: $189K
9% more funds holding
Funds holding: 56 → 61 (+5)
0.5% more ownership
Funds ownership: 4.12% → 4.63% (+0.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
61
Holders Change
+5
Holders Change %
+8.93%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
24
Reduced
13
Closed
8
Calls
$297K
Puts
$189K
Net Calls
+$108K
Net Calls Change
+$44K
Top Buyers
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.26M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$2.23M |
| 3 |
NC
Nexthera Capital
New York
|
+$1.63M |
| 4 |
AG
Artal Group
Luxembourg
|
+$1.41M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.23M |
Top Sellers
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.42M |
| 2 |
Renaissance Technologies
New York
|
-$727K |
| 3 |
RA
Royce & Associates
New York
|
-$587K |
| 4 |
SIM
Spark Investment Management
New York
|
-$393K |
| 5 |
D.E. Shaw & Co
New York
|
-$276K |
